SCHEMBL6558264

SCHEMBL6558264

CC(N)C=Cc1cncnc1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6558261 1.00 NFE2L2 (0.30) NFE2L2
SCHEMBL13334636 0.74 HTR2A (0.56)
SCHEMBL7738081 0.74 HTR2A (0.56)
Hydrochloric Acid SCHEMBL3324772 0.72 HTR2A (0.55)
SCHEMBL3662234 0.69
SCHEMBL18105222 0.69
SCHEMBL144445 0.68 HTR2A (0.55)
SCHEMBL7296999 0.68 HTR2A (0.55)
SCHEMBL19586405 0.68 HTR2A (0.55)
SCHEMBL144446 0.68 HTR2A (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0873050-B1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS TARGACEPT INC (US) 2004-03-10 EP claimed